Rachel Rosenthal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rachel Rosenthal has a total of 151 co-authors. Here are the top co-authors by number of shared publications:
- Charles Swanton
Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK
14 shared publications - Sergio A. Quezada
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK
13 shared publications - Adam Pennycuick
UCL Respiratory, University College London, London, UK
12 shared publications - Andrew J.S. Furness
The Royal Marsden Hospital , London, SW3 6JJ
12 shared publications - Ayse U. Akarca
Department of Cellular Pathology, University College London Hospitals, London, UK
12 shared publications - Bernadette Carroll
School of Biochemistry and Biomedical Sciences, University of Bristol, Biomedical Science Building, Bristol, UK
12 shared publications
Latest Publications
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S5 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Pathway analysis comparing the illumina and Affymetrix datasets as described in Supplementary Methods.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Pathway analysis comparing the illumina and Affymetrix datasets as described in Supplementary Methods.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S4 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S3 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Immune cell deconvolution from molecular data. Relative proportions of immune cell subtypes are predicted from gene expression data using the Danaher method, and from methylation data using methylCIBERSORT. Differences between progressive and regressive groups are reported here.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Immune cell deconvolution from molecular data. Relative proportions of immune cell subtypes are predicted from gene expression data using the Danaher method, and from methylation data using methylCIBERSORT. Differences between progressive and regressive groups are reported here.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S3 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S2 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S1 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Details of molecular investigations performed on each sample. Clinical and outcome data is also presented. In all cases with a previous history of lung cancer, this was of squamous histology.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Details of molecular investigations performed on each sample. Clinical and outcome data is also presented. In all cases with a previous history of lung cancer, this was of squamous histology.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S2 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Markers used to define cell types in quantitative multiplex immunohistochemistry experiments.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Markers used to define cell types in quantitative multiplex immunohistochemistry experiments.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Table S1 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Details of molecular investigations performed on each sample. Clinical and outcome data is also presented. In all cases with a previous history of lung cancer, this was of squamous histology.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer
Details of molecular investigations performed on each sample. Clinical and outcome data is also presented. In all cases with a previous history of lung cancer, this was of squamous histology.